• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

HHS

AdvaMed weighs in on Dr. Oz’s selection to lead CMS

November 19, 2024 By Jim Hammerand

President-elect Donald Trump today said he is nominating Dr. Mehmet Oz to serve as administrator of the Centers for Medicare & Medicaid Services (CMS). Oz would serve under Robert F Kennedy Jr. — who Trump nominated as secretary of the U.S. Department of Health and Human Services — if Oz and Kennedy are confirmed by […]

Filed Under: Featured, News Well Tagged With: AdvaMed, Centers for Medicare and Medicaid Services (CMS), CMS, HHS, U.S. Department of Health and Human Services

HHS OIG will review FDA’s approval of Biogen’s aducanumab

August 4, 2021 By Brian Buntz

The HHS Office of Inspector General will review FDA’s accelerated approval pathway following the controversy surrounding the agency’s approval of the Alzheimer’s drug Aduhelm (aducanumab) from Biogen (NSDQ:BIIB) and Eisai (TYO:4523). Among the controversies surrounding the drug’s approval is the use of the accelerated approval pathway, which led the agency to use a surrogate endpoint to approve aducanumab conditionally.  […]

Filed Under: Featured, Pharmaceutical Tagged With: Aducanumab, Aduhelm, Biogen, Eisai, FDA, HHS

Biden administration invests $3B to accelerate development of next-gen COVID-19 treatments

June 17, 2021 By Chris Newmarker

President Joe Biden’s administration will spend $3 billion in American Rescue Plan money to accelerate the discovery, development and manufacturing of antiviral medicines against COVID-19, HHS announced today. Not only will the  Antiviral Program for Pandemics seek to boost the availability of medicines to prevent serious COVID-19 illness and save lives, but it will pursue […]

Filed Under: Business/Financial News, Featured, Pharmaceutical, Research & Development Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), HHS, Joe Biden

Xavier Becerra confirmed as HHS secretary

March 18, 2021 By Sean Whooley

The U.S. Senate narrowly voted to confirm Xavier Becerra as the U.S. Dept. of Health & Human Services (HHS) secretary today. Becerra received the nomination for the position from President Joe Biden in December 2020. Today, the Senate voted 50-49 in favor of Becerra, who will have to resign his seat as California’s attorney general. […]

Filed Under: Business/Financial News, Featured, Healthcare Reform, Medicare, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), HHS, Joe Biden, U.S. Senate

HHS ends more ventilator contracts as national stockpile fills up

September 2, 2020 By Sean Whooley

The U.S. Dept. of Health and Human Services (HHS) is reportedly terminating more ventilator contracts as the national stockpile is full. The Hill reported today that HHS is throwing out some of the contracts that totaled $3 billion as the U.S. government sought to supply as many ventilators as possible during the first surge of […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Respiratory Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Hamilton Medical, HHS, Philips, Ventec Life Systems, Vyaire Medical

Ventec, GM complete HHS ventilator contract

September 1, 2020 By Sean Whooley

Ventec Life Systems and General Motors announced today that they completed their government contract to produce 30,000 ventilators. The two companies kicked off mass production of Ventec’s V+Pro critical care ventilator at GM’s Kokomo, Ind., plant in April, having received a $489.4 million contract from the U.S. Dept. of Health and Human Services to deliver […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Respiratory Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), General Motors, GM, HHS, Ventec Life Systems

HHS pulls FDA back from regulating some COVID-19 tests

August 21, 2020 By Chris Newmarker

FDA will no longer require a premarket review of laboratory-developed tests during the COVID-19 pandemic, according to a decision announced on the U.S. Department of Health and Human Services website. Such a requirement in the future will need notice-and-comment rulemaking versus guidance documents, compliance manuals, website statements or other informal issuances, HHS said in the decision […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), FDA, HHS

HHS puts $6.5M more toward COVID-19 testing

August 13, 2020 By Nancy Crotti

The U.S. Department of Health and Human Services (HHS) said today it will provide a total of $6.5 million to help two commercial diagnostic laboratories to expand capacity to conduct up to 4 million additional diagnostic tests for COVID-19 per month. The investments in Aegis Sciences (Nashville, Tenn.) and in Sonic Healthcare USA (Austin, Texas) […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: Aegis Sciences, Beckman Coulter Inc., coronavirus, COVID-19, HHS, Sonic Healthcare USA, Thermo Fisher Scientific, U.S. Department of Health and Human Services

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy